| CTC phenotype (n%) | |||
---|---|---|---|---|
Patient groups | I | II | III | IV |
 | Dormant only a | Proliferative b | Apoptotic c | All phenotypes e |
Dormancy candidates (n = 40) | 25 (62.5) | 7 (17.5) | 4 (10) | 4 (10) |
Metastatic patients (n = 15) | 8 (53.4) | 7 (46.6)* | 0 (0) | 0 (0) |
 | CTC phenotype (n %) | |||
 | Dormant a |      Nondormant d | ||
Number of CTCs | Â | Proliferative b | Apoptotic c | |
Dormancy candidates (n = 244) | 201 (82.4) | 14 (5.7) | 29 (11.9) | |
Metastatic patients (n = 142) | 84 (59.1)** | 58 (40.9)** | 0 (0) |